298 related articles for article (PubMed ID: 16923962)
1. Hormonal control of androgen receptor function through SIRT1.
Fu M; Liu M; Sauve AA; Jiao X; Zhang X; Wu X; Powell MJ; Yang T; Gu W; Avantaggiati ML; Pattabiraman N; Pestell TG; Wang F; Quong AA; Wang C; Pestell RG
Mol Cell Biol; 2006 Nov; 26(21):8122-35. PubMed ID: 16923962
[TBL] [Abstract][Full Text] [Related]
2. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
3. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.
Fu M; Wang C; Reutens AT; Wang J; Angeletti RH; Siconolfi-Baez L; Ogryzko V; Avantaggiati ML; Pestell RG
J Biol Chem; 2000 Jul; 275(27):20853-60. PubMed ID: 10779504
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
[TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.
Fu M; Wang C; Wang J; Zhang X; Sakamaki T; Yeung YG; Chang C; Hopp T; Fuqua SA; Jaffray E; Hay RT; Palvimo JJ; Jänne OA; Pestell RG
Mol Cell Biol; 2002 May; 22(10):3373-88. PubMed ID: 11971970
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner.
Reutens AT; Fu M; Wang C; Albanese C; McPhaul MJ; Sun Z; Balk SP; Jänne OA; Palvimo JJ; Pestell RG
Mol Endocrinol; 2001 May; 15(5):797-811. PubMed ID: 11328859
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.
Dai Y; Ngo D; Forman LW; Qin DC; Jacob J; Faller DV
Mol Endocrinol; 2007 Aug; 21(8):1807-21. PubMed ID: 17505061
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.
Kobayashi Y; Furukawa-Hibi Y; Chen C; Horio Y; Isobe K; Ikeda K; Motoyama N
Int J Mol Med; 2005 Aug; 16(2):237-43. PubMed ID: 16012755
[TBL] [Abstract][Full Text] [Related]
13. Mammalian SIRT1 represses forkhead transcription factors.
Motta MC; Divecha N; Lemieux M; Kamel C; Chen D; Gu W; Bultsma Y; McBurney M; Guarente L
Cell; 2004 Feb; 116(4):551-63. PubMed ID: 14980222
[TBL] [Abstract][Full Text] [Related]
14. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
Wu K; Katiyar S; Witkiewicz A; Li A; McCue P; Song LN; Tian L; Jin M; Pestell RG
Cancer Res; 2009 Apr; 69(8):3347-55. PubMed ID: 19351840
[TBL] [Abstract][Full Text] [Related]
15. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
17. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells.
Yeap BB; Krueger RG; Leedman PJ
Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
19. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
20. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
